ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age [clear]
Topic Area [clear]
Experience [clear]
Course Format
SIG
Instructional Level
Results 1 - 10 of 20
Presenter(s): Sharon G. Kujawa, PhD, CCC-A
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: Noise exposure and aging are common causes of acquired sensorineural hearing loss, marked by damaged hair cells and evident in threshold audiograms. Recent studies have shown that well before overt hearing loss is apparent, a more insidious process frequently occurs, one that doesn’t kill hair cells, but instead permanently interrupts their communication with cochlear neurons. This cochlear synaptic loss can be dramatic, even in ears with normal threshold audiograms, where it has been called “hidden hearing loss.” This webinar will review hidden and overt effects of noise and aging on the ear and hearing, focusing on documented synaptopathic and neurodegenerative outcomes and predicted functional consequences, including speech-in noise difficulties, tinnitus, and hyperacusis.
Presenter(s): Alyssa Whinna, AuD; Michael Hoffer, MD; James Buskirk, PT, SCS
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This session provides an interdisciplinary (audiology, otology, and physical therapy) perspective on management of patients with dizziness, specifically geared toward cutting-edge management techniques and recommendations for care. The panel presentation discusses surgical and nonsurgical approaches and clinical cases to highlight patient benefits and improved clinical outcomes. A question-and-answer period concludes the presentation. This course was presented and recorded at the 2019 ASHA Convention. The session was developed by, and presenters invited by, Hearing, Vestibular, Tinnitus - Assessment and Intervention: Adult.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Richard Gans, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: The evaluation and non-medical management of balance disorders in children and adults is an exciting and growing opportunity for audiologists to participate in this important aspect of health care services. This presentation highlights the most common conditions throughout the life span from neonate to geriatric and includes an evidence-based clinical pathway model of gold-standard evaluation protocols and management strategies. This course was presented and recorded at the 2019 ASHA Convention. This session was developed by, and presenter invited by, SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Konstantina M. Stankovic, MD, PhD, FACS; Lauren Calandruccio, PhD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: The presenters discuss their work on optical imaging of the inner ear to enable progress in understanding, diagnosing, and treating human sensorineural hearing loss (SNHL). Next, they illustrate their approach to develop personalized therapies for SNHL, using vestibular schwannoma as an example. Finally, they demonstrate the promise of gene therapy, nanotechnology, and computational drug repositioning. This course was presented and recorded at the 2019 ASHA Convention.
Presenter(s): William H Shapiro, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses auditory brainstem implants (ABI) as an option for individuals who typically cannot benefit from conventional amplification or cochlear implants as they don't have an implantable cochlea or functioning 8th nerve. The session describes the ABI journey from candidacy to surgery to activation and follow-up. The speaker discusses the history of ABI, anatomy of the auditory pathway, interprofessional education and interprofessional practice related to ABI, and ABI clinical trial data.
Presenter(s): Gina Angley, AuD, CCC-A; Colleen Ittner, AuD, CCC-A
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This presentation provides an overview of the clinical use of bone conduction hearing devices across the life span. It includes information about clinically available devices, guidelines related to non-surgical and surgical options, and pediatric and adult case studies. The presenters highlight key components of patient assessment, candidacy criteria, and device fitting. This course was presented and recorded at the 2019 ASHA Convention. The session was developed by, and presenters invited by, Hearing and Vestibular - Assessment and Intervention: Pediatric, Audiology Implantables, and Hearing, Vestibular, Tinnitus: Assessment and Intervention: Adult.
Presenter(s): Lauren Calandruccio, PhD, CCC-A
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: The likelihood of encountering multilingual individuals, non-English-speaking individuals, and non-native speakers of English in the clinic is becoming more common. As audiologists are working with linguistically diverse populations, they may find themselves asking, “How should I evaluate speech perception in my patients who are not monolingual speakers of English? Which speech materials should I use?” This on demand webinar reviews the current literature on multilingual and non-native speech perception and discusses approaches to best serve patients from diverse linguistic backgrounds.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Deb Culbertson, PhD, CCC-A; Rachel Glade, PhD, CCC-SLP, LSLS Cert. AVT; Christy Ray, PhD, CCC-SLP; Elizabeth Rosenzweig, PhD,CCC-SLP,LSLS Cert. AVT; Erin Stefancin,MA, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This course features moderated discussions among a panel of clinicians who collectively provide cochlear implant auditory rehabilitation (AR) to patients of all ages. Topics and discussions demonstrate the need to expand and differentiate intervention approaches based on the unique needs of individual patients with cochlear implants. Panelists review recent studies, present translational applications, share case studies and examples, illustrate multidisciplinary professional roles, and discuss evidence-based assessment and treatment. This course – part of the SIGnature Series – was developed by SIG 7: Aural Rehabilitation and Its Instrumentation.
<< < 1 2 >>